Exploring the Question: What Medication Helps with Liver Function?

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects an estimated 25 to 30 percent of the U.S. population, highlighting the urgent need for effective treatments [1.2.4]. When considering what medication helps with liver function, the answer depends entirely on the underlying cause of the liver problem.

Quick Summary

A comprehensive overview of medications for various liver conditions. It covers newly approved drugs for MASH, management of cirrhosis complications, antiviral agents for hepatitis, and other supportive therapies for liver health.

Key Points

• Specific to the Cause: No single medication helps all liver problems; treatment is tailored to the specific disease like MASH, cirrhosis, or hepatitis [1.3.1, 1.4.4].

• MASH Breakthroughs: The FDA recently approved the first-ever drugs for MASH: Resmetirom (Rezdiffra) in 2024 and Semaglutide in 2025 [1.2.3, 1.2.2, 1.3.6].

• Cirrhosis Management: Medications for cirrhosis do not cure the disease but manage severe complications like fluid buildup (diuretics) and brain function changes (lactulose) [1.6.2, 1.6.3].

• Hepatitis C is Curable: Modern Direct-Acting Antivirals (DAAs) can cure most Hepatitis C infections in 8-12 weeks with a simple course of oral tablets [1.7.3].

• Alcoholic Hepatitis Treatment: Severe alcoholic hepatitis is treated with corticosteroids like Prednisolone to reduce inflammation, but alcohol cessation is the most vital step [1.5.1, 1.5.3].

• UDCA for Cholestasis: Ursodeoxycholic Acid (UDCA) is a key treatment for cholestatic conditions like Primary Biliary Cholangitis (PBC), working by protecting liver cells from toxic bile acids [1.8.1, 1.8.3].

• Lifestyle is Key: Across most liver conditions, medications are used in conjunction with lifestyle interventions such as diet, exercise, and avoiding alcohol [1.2.4, 1.5.1].

Understanding Liver Disease and Treatment Approaches

The liver is a vital organ responsible for detoxification, metabolism, and producing essential proteins. When it's damaged, its ability to perform these functions is compromised. Liver disease encompasses a range of conditions, including metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH), alcoholic hepatitis, viral hepatitis, and cirrhosis. Treatment is not one-size-fits-all; the specific medication used to help liver function targets the root cause of the damage [1.3.1, 1.4.4]. Lifestyle changes, such as diet, exercise, and alcohol cessation, are foundational in managing most liver conditions [1.2.4, 1.5.1].

Breakthrough Medications for MASH (Fatty Liver Disease)

For many years, there were no FDA-approved medications specifically for MASH, an advanced form of fatty liver disease characterized by inflammation and scarring (fibrosis) [1.4.2]. This has recently changed, marking a new era in hepatology.

• Resmetirom (Rezdiffra): In 2024, the FDA granted accelerated approval to Resmetirom, the first drug specifically for MASH with moderate to advanced liver fibrosis [1.2.3, 1.2.6]. It is a thyroid hormone receptor beta agonist that works by helping the liver break down fat, which in turn reduces inflammation and scarring [1.2.5, 1.2.1]. Clinical trials showed it resolved MASH in up to 30% of patients and improved fibrosis in up to 26% [1.2.6, 1.4.3]. It is intended to be used alongside diet and exercise [1.3.5].
• Semaglutide (Wegovy): Originally known as a weight-loss and diabetes drug, Semaglutide gained FDA approval in August 2025 for treating MASH [1.2.2, 1.3.6]. As a GLP-1 receptor agonist, it helps by reducing body weight, improving insulin resistance, and lowering systemic inflammation, all of which contribute to reducing liver fat and injury [1.2.2]. In trials, 63% of patients on semaglutide saw MASH resolution without worsening fibrosis [1.2.2, 1.3.6].

Managing Complications of Cirrhosis

Cirrhosis is advanced scarring of the liver, which is generally not reversible. Medications for cirrhosis focus on managing its life-threatening complications [1.6.3].

• Ascites (Fluid Buildup): Diuretics, or "water pills," are used to help the body eliminate excess fluid. The most common combination is Spironolactone (Aldactone) and Furosemide (Lasix) [1.6.1, 1.6.2].
• Hepatic Encephalopathy (HE): When the liver fails, toxins can build up and affect the brain. Lactulose, a syrup-like laxative, helps remove these toxins by promoting bowel movements [1.3.1]. Rifaximin, an antibiotic, also helps by reducing toxin-producing bacteria in the gut [1.3.1, 1.6.2].
• Portal Hypertension & Variceal Bleeding: High blood pressure in the portal vein can cause enlarged veins (varices) that are at risk of bleeding. Non-selective beta-blockers like Propranolol and Carvedilol lower this pressure to reduce bleeding risk [1.3.1, 1.6.2].

Medications for Other Liver Conditions

Alcoholic Hepatitis

For severe alcoholic hepatitis, the primary treatments aim to reduce liver inflammation. Corticosteroids, particularly Prednisolone, are often used as a first-line therapy, though they only offer modest short-term survival gains and are not suitable for patients with infections or kidney failure [1.5.1, 1.5.3, 1.5.4]. Pentoxifylline may be used as a second-line option, but evidence for its effectiveness is mixed [1.5.3, 1.5.4]. Abstinence from alcohol remains the most critical intervention [1.5.1].

Viral Hepatitis C

Treatment for Hepatitis C has been revolutionized by Direct-Acting Antivirals (DAAs). These oral medications offer a cure for over 95% of patients with a treatment course of just 8-12 weeks [1.7.3, 1.7.4]. Common DAA regimens include:

• Glecaprevir/pibrentasvir (Mavyret) [1.7.2]
• Sofosbuvir/velpatasvir (Epclusa) [1.7.2]
• Ledipasvir/sofosbuvir (Harvoni) [1.7.2]
• Sofosbuvir/velpatasvir/voxilaprevir (Vosevi) [1.7.3]

Cholestatic Liver Diseases

• Ursodeoxycholic Acid (UDCA): This bile acid is the primary treatment for Primary Biliary Cholangitis (PBC). It works by protecting liver cells from the toxic effects of other bile acids, stimulating bile flow, and reducing inflammation [1.8.1, 1.8.3]. It helps dissolve certain types of gallstones and is used in other cholestatic disorders [1.8.2, 1.6.1].
• Obeticholic Acid (Ocaliva): This medication is also used for PBC but comes with significant warnings. The FDA has restricted its use in patients with advanced cirrhosis due to the risk of serious liver injury and failure [1.9.1, 1.9.4].

Comparison of Common Liver Medications

Medication Class	Example(s)	Primary Use	Mechanism of Action	Key Considerations
THR-β Agonist	Resmetirom (Rezdiffra)	MASH with fibrosis	Activates a thyroid hormone receptor in the liver to increase fat metabolism [1.2.1, 1.2.5].	First drug specifically approved for MASH; used with diet/exercise [1.2.3, 1.3.5].
GLP-1 Agonist	Semaglutide (Wegovy)	MASH, Type 2 Diabetes	Reduces weight, improves insulin resistance, and lowers inflammation [1.2.2].	Also a popular weight-loss drug; treats multiple aspects of metabolic syndrome [1.2.2].
Diuretics	Spironolactone, Furosemide	Ascites (from cirrhosis)	Help the kidneys remove excess salt and water from the body [1.6.1, 1.6.2].	Requires monitoring of electrolytes and kidney function [1.6.5].
Beta-Blockers	Propranolol, Carvedilol	Portal Hypertension	Lower blood pressure in the main vein to the liver, reducing bleeding risk [1.3.1, 1.6.2].	Dose is titrated to achieve a target heart rate [1.6.5].
DAAs	Mavyret, Epclusa, Harvoni	Hepatitis C	Directly interfere with the hepatitis C virus's ability to replicate [1.7.3].	Offer a cure in over 95% of cases with short treatment duration [1.7.3, 1.7.4].
Bile Acids	Ursodeoxycholic Acid (UDCA)	PBC, Gallstones	Replaces toxic bile acids, protects liver cells, and stimulates bile flow [1.8.1, 1.8.3].	Generally safe and well-tolerated [1.8.1].

Conclusion

The landscape of medications that help with liver function is rapidly evolving, especially with recent breakthroughs for MASH. However, the correct pharmacological approach is highly specific to the diagnosis, whether it's managing complications of cirrhosis with diuretics and beta-blockers, curing viral hepatitis with DAAs, or reducing inflammation in alcoholic hepatitis with steroids. In all cases, these medications are most effective when combined with lifestyle modifications and under the guidance of a healthcare professional.

---

For further information, consider visiting this authoritative resource: Treatment for NAFLD & NASH - NIDDK [1.4.5]

Frequently Asked Questions

What is the newest medication for fatty liver disease?

The newest FDA-approved medications for the advanced form of fatty liver disease called MASH (formerly NASH) are Resmetirom (brand name Rezdiffra), approved in 2024, and Semaglutide, approved for MASH in August 2025 [1.2.3, 1.2.2, 1.3.6].

Can medication reverse liver damage?

Some medications can help reverse certain types of liver damage. For MASH, drugs like Resmetirom can reverse fibrosis (scarring) [1.2.6]. For viral hepatitis C, antiviral drugs can cure the infection, stopping further damage. However, advanced cirrhosis is generally considered irreversible [1.6.3].

What medications are used for cirrhosis of the liver?

Medications for cirrhosis manage complications. These include diuretics like Spironolactone and Furosemide for fluid retention, beta-blockers like Propranolol to prevent bleeding, and Lactulose or Rifaximin to treat confusion (hepatic encephalopathy) [1.6.2, 1.3.1].

Are there over-the-counter medications that help the liver?

No over-the-counter medications are approved to treat specific liver diseases. You should talk with your doctor before using any dietary supplements, as some herbal remedies can actually damage your liver [1.4.5]. Vitamin E is sometimes recommended for non-diabetic MASH patients, but its long-term safety is debated [1.4.2].

What is the treatment for alcoholic liver disease?

The most important treatment is to stop drinking alcohol completely [1.5.1]. For severe inflammation (alcoholic hepatitis), doctors may prescribe corticosteroids like Prednisolone to reduce inflammation and improve short-term survival [1.5.3].

How does Ursodeoxycholic acid (UDCA) help the liver?

UDCA is a therapeutic bile acid primarily used for cholestatic liver diseases like PBC. It protects liver cells (hepatocytes) from damage caused by toxic bile acids, stimulates bile flow, and has immunomodulating effects [1.8.1, 1.8.3].

What are Direct-Acting Antivirals (DAAs)?

DAAs are a class of oral medications that have revolutionized the treatment of Hepatitis C. They work by directly targeting and blocking proteins the virus needs to replicate, leading to a cure in over 95% of patients, often within 8-12 weeks [1.7.3, 1.7.5].